Home2024-02-25T09:14:32+02:00

Prof. Dr. med. Markus Hufnagel, DTM&H

Dr. Markus HufnagelDr. Markus Hufnagel is a specialist in pediatric and adolescent medicine, infectious diseases, pediatric rheumatology, immunology, tropical medicine, travel medicine and vaccinology. As Director of Pediatric Rheumatology and Pediatric Infectious Diseases at the University Children's Hospital in Freiburg, Germany, Dr. Hufnagel is responsible for patient care and care management, medical teaching and medical research. His current research focuses on antibiotic usage and resistance, epidemiology of COVID-19, infections with gram-positive pathogens, medical care of refugees and quality of care of pediatric rheumatology patients. Active in numerous international projects, Dr. Hufnagel regularly collaborates with European and North American partners, as well as with several NGOs working in resource-poor countries.

PROFESSIONAL EXPERIENCE

Curriculum Vitae

At present
  • Professor of Pediatric and Adolescent Medicine (since 2016)
  • Director of Pediatric Rheumatology and Pediatric Infectious Diseases (since 2023)
  • Attending Physician ("Oberarzt" since 2010)
  • Infectious Diseases Specialist (Board Certified as of 2009)
  • Pediatric Rheumatologist (Board Certified as of 2010)
  • Immunologist (Board Certified as of 2021)
  • Lecturer in Pediatric Infectious Diseases, Tropical Medicine, Travel Medicine, Vaccinology,
    Immunology and Rheumatology
    (since 2005)
    University Children's Hospital, Freiburg, Germany
2010 – 2012
  • Attending Physician ("Oberarzt" since 2010)
  • Director of Pediatric Rheumatology and Deputy Director of Pediatric Infectious Diseases (2010 – 2022)
  • Director of Pediatric Outpatient Clinic (2010 – 2012)
    University Children's Hospital, Freiburg, Germany
2009
2007 – 2008
Apr – May 2007
2005 – 2007
2003 – 2005
2000 – 2003
1995 – 2000
1994
1992 – 1994

International Visiting Lectureships

Sept – Oct 2022
Nov 2014
Sept – Oct 2013
Nov 2011
July 2011
Mar 2010
Dec 2008

TRAINING

Education, Training & Degrees

2022 &
2016, 2013, 2009
  • Good Clinical Practice (GCP) Training Certification, Mainz, Germany
    (Initial certification followed by recertification in subsequent years)
2021
  • Board Certification as Immunologist ("Zusatzweiterbildung")
2019
2018
2016
2012
  • Course for Coordinating Investigators ("Studienleiterkurs")
2010
  • Board Certification as Pediatric Rheumatologist ("Zusatzweiterbildung")
2009
  • Board Certification as Physician for Infectious Diseases ("Zusatzweiterbildung")
2009
  • Certification of PhD Degree Equivalency and Associate Professor Status
    PhD in Bacterial Immunology in accordance with official U.S. guidelines
2009
2007
2005
  • Board Certification as Physician for Pediatrics and Adolescent Medicine ("Facharzt")
1995
1994
1994
  • Medical License ("Approbation als Arzt")
1992
  • Medical Certification ("Medizinisches Staatsexamen")
1984 – 1992
  • Medical School, Study of Human Medicine
    – Friedrich-Alexander University, Erlangen, Germany
    – Albert-Ludwig University, Freiburg, Germany
    – University of Basel, Basel, Switzerland
    – University of Cape Town, Cape Town, South Africa

AFFILIATIONS

Professional Memberships

DGKJ
DGPI
GKJR
GTP
ESPID
AGPRS

Grants, Fellowships & Awards

Stern Ärzteliste
2022
2014
2013
2011
2011
2010
2008
2005
1999

PUBLICATIONS

Original Research

Milatz F, Hansmann S, Klotsche J, Niewerth M, Kallinich T, Dressler F, Haas JP, Berendes R, Horneff G, Hufnagel M, Weller-Heinemann F, Windschall D, Trauzeddel R, Klaas M, Girschick H, Oomen PT, Foeldvari I, Cantez MS, Jansson AF, Hartmann M, Peitz-Kornbrust J, Minden K (2024).
Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: Results from a German nationwide prospective observational cohort study. .
Pediatric Rheumatology 22:39 DOI: 10.1186/s12969-024-00976-2 Language: English
article icon Abstract

Kuemmerle-Deschner JB, Kallinich T, Henes J, Kortus-Goetze B, Oommen PT, Rech J, Weller-Heinemann F, Horneff G, Janda A, Foeldvari I, Schutz C, Dressler F, Borte M, Hufnagel M, Braner A, Meier F, Fiene M, Krickau T, Andreica I, Weber-Arden J, Blank N (2024).
The long-term safety and efficacy of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry.
Rheumatic & Musculosceletal Diseases Open 10 DOI: 10.1136/rmdopen-2023-003890 Language: English
article icon Abstract

Maximilian David Mauritz, Ulrich von Both, Christian Dohna‑Schwake, Christian Gille, Carola Hasan, Johannes Huebner, Markus Hufnagel, Markus Knuf, Johannes G. Liese, Hanna Renk, Henriette Rudolph, Ulf Schulze‑Sturm, Arne Simon, Florian Stehling, Tobias Tenenbaum, Boris Zernikow (2024).
Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment in Germany.
European Journal of Pediatrics 2024;183 DOI: 10.1007/s00431-023-05401-6 Language: English
article icon Abstract

Brunner HI, Foeldvari I, Alexeeva E, Ayaz NA, Calvo Penades I, Kasapcopur O, Chasnyk VG, Hufnagel M, Zuber Z, Schulert GS, Ozen S, Rakhimyanova A, Ramanan A, Scott C, Sozeri B, Zholobova E, Martin R, Zhu X, Whelan S, Pricop L, Martini A, Lovell DJ and Ruperto N, on behalf of Paediatric Rheumatology INternational Trials Organization (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG) (2023).
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial.
Annals of Rheumatic Diseases 82:154-60 DOI: 10.1136/ard-2022-222849 Language: English
article icon Abstract

Papan C, Reifenrath K, Last K, Attarbaschi A, Graf N, Groll AH, Hübner J, Laws HJ, Lehrnbecher T, Liese J, Martin L, Tenenbaum T, Weichert S, Vieth S, von Both U, Hufnagel M, Simon A, for the Study Group "Antibiotic Stewardship" of the DGPI and the Study Group "Febrile Neutropenia" of the GPOH (2022).
Study protocol for a multi-center point-prevalence study with qualitative expert panel assessment of antimicrobial use in pediatric oncology and hematology.
JMIR Research Protocols 11:e35774 DOI: 10.2196/35774 Language: English
article icon Abstract

Sorg AL, Bergfeld L, Jank M, Corman V, Semmler I, Görtz A, Beyerlein A, Verjans E, Wagner N, von Bernuth H, Lander F, Weil K, Hufnagel M, Spiekerkoetter U, Cho-Ming C, Nährlich L, Muntau AC, Schulze-Sturm U, Hansen G, Wetzke M, Jung AM, Niehues T, Fricke-Otto S, von Both U, Huebner J, Behrends U, Liese JG, Schwerk C, Drosten C, von Kries R, Schroten H (2022).
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021.
Nature Communications 13(1):3128 DOI: 10.1038/s41467-022-30482-6 Language: English
article icon Abstract

Ruperto N, Brunner H, Ramanan A, Horneff G, Cuttica R, Henrickson M, Lopez JA, Boteanu AL, Calvo Penades I, Minden K, Schmeling H, Hufnagel M, Weiss JE, Pardeo M, Nanda A, Roth J, Rubio-Perez N, Hsu JC, Wimalasundera S, Wells C, Bharucha K, Douglass W, Bao M, Mallalieu NL, Martini A, Lovell D, De Benedetti F for the Paediatric Rheumatology International Trial Organization (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG). (* Dr. Markus Hufnagel is a contributing member of the PRINTO Study Group) (2021).
Subcutaneous dosing regimen of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.
Rheumatology 60:4568-4580 DOI: 10.1093/rheumatology/keab047 Language: English
article icon Abstract

Kohns Vasconcelos M, Loens K, Sigfrid L, Iosifidis E, Epalza C, Dona D, Papachristou S, Roilides E, Gijon M, Rojo P, Minotti C, Da Dalt L, Islam S, Jarvis J, Syggelou A, Tsolia M, Nyirenda Nyang'wa M, Keers S, Renk H, Gemmel AL, D'Amore C, Ciofi degli Atti M, Rodriguez-Tenreiro Sanchez C, Martinon-Torres F, Burokiene S, Goetghebuer T, Spoulou V, Riordan A, Calvo C, Gkentzi D, Hufnagel M, Openshaw P, Goossens H, Leven G, Fraaij P, Giaquinto C, Bielicki JA, Horby P, Sharland M (2021).
Aetiology of acute respiratory tract infection in pre-school children requiring hospitalisation in Europe – results from the PED-MERMAIDS multi-centre case-control study.
BMJ Open Respiratory Research 8:e000887 DOI: 10.1136/bmjresp-2021-000887 Language: English
article icon Abstract

Quartier P, Alexeeva E, Tamàs C, Chasnyk V, Wulffraat N, Palmblad K, Wouters C, Brunner H, Marzan K, Schneider R, Horneff G, Martini A, Anton J, Wei X, Slade A, Ruperto N, Abrams K; Pediatric Rheumatology International Trials Organization (PRINTO), the Pediatric Rheumatology Collaborative Study Group (PRCSG). (* Dr. Markus Hufnagel is a contributing member of the PRINTO Study Group) (2021).
Tapering Canakinumab Monotherapy in Patients with Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results from an Open-label, Randomized Phase IIIb/IV Study.
Arthritis Rheumatology 73:336-346 DOI: 10.1002/art.41488 Language: English
article icon Abstract

Kuntz M, Kohlfürst DS, Feiterna-Sperling C, Krüger R, Baumann U, Buchtala L, Elling R, Grote V, Hübner J, Hufnagel M, Kaiser-Labusch P, Liese J, Otto EM, Rose MA, Schneider C, Schuster V, Seidl M, Sommerburg O, Vogel M, von Bernuth H, Weiß M, Zimmermann T, Nieters A, Zenz W, and Henneke P for the NTMkids consortium (2020).
Season, sex and surgery: Risk factors for complicated lymphadenitis caused by non-tuberculous mycobacteria in children.
Emerging Infectious Diseases 26:579-586 DOI: 10.3201/eid2603.191388 Language: English
article icon Abstract

Bélard S, Brand J, Schulze-Sturm U, Janda A, von Both U, Tacoli C, Alberer M, Kempf C, Stegemann MS, Krüger R, Varnholt V, Blohm M, Reiter K, Zoller T, Suttorp N, Mall M, von Bernuth H, Gratopp A, Hübner J, Hufnagel M, Kobbe R, Kurth F (2019).
Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany: A Retrospective Study.
Pediatric Infectious Diseases Journal 38:e295-e300 DOI: 10.1097/INF.0000000000002417 Language: English
article icon Abstract

Hsia Y, Lee BR, Versporten A, Yang Y, Bielicki J, Jackson C, Newland J, Goossens H, Magrini N, Sharland M on behalf of the GARPEC and Global-PPS networks. (*Dr. Hufnagel is a contributing member of the GARPEC and Global-PPS networks) (2019).
Using the WHO Access/Watch/Reserve classification to define patterns of hospital antibiotic use: analysis of pediatric point prevalence survey data from 56 countries. The first AWaRe PPS.
Lancet Global Health 7:e861-871 DOI: 10.1016/S2214-109X(19)30071-3 Language: English
article icon Abstract

Brunner HI, Holland MJ, Beresford MW, Ardoin SP, Appenzeller S, Silva CA, Flores F, Goilav B, Avar Aydin PO, Wenderfer SE, Levy DM, Ravelli A, Khubchandani R, Avcin T, Klein-Gitelman MS, Ruperto N, Feldman BM, Ying J; Paediatric Rheumatology International Trial Organisation and Pediatric Rheumatology Collaborative Study Group. (*Dr. Hufnagel is a contributing member of the Paediatric Rheumatology International Trial Organization) (2019).
American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus.
Arthritis Care & Research 71:579-90 DOI: 10.1002/acr.23834 Language: English
article icon Abstract

Lehrnbecher T, Groll AH, Agyeman P, Amman RA, Attarbaschi A, Behrends U, Berger C, Hamprecht A, Hufnagel M, Laws HJ, Scheler M, Temme C, Vieth S, Simon A für die Arbeitsgemeinschaften "Infektionen" der GPOH und "Fieber bei Neutropenie" der DGPI (2018).
Recommendations for Diagnostics and Therapy of Children with Cancer Presenting with Fever and Neutropenia - Comparison of Two Current Guidelines. Empfehlungen zur Diagnostik und Therapie bei krebskranken Kindern mit Fieber und Granulozytopenie - Vergleich zweier aktueller Leitlinien
Klinische Pädiatrie 230:115-121 DOI: 10.1055/s-0044-101953 Language: German
article icon Abstract

Schwarz T, Oommen PT, Windschall D, Weissbarth-Riedel E, Trauzeddel R, Grote V, von Bismarck P, Morbach H, Hofmann C, Holl-Wieden A, Hügle B, Schnabel A, Dedeoglu F, Ferguson PJ, Zhao Y, Borte M, Haas JP, Hufnagel M, Hedrich CM, Girschick HJ, Jansson AF für die PRO-KIND CNO-Projektgruppe (2018).
Protocols for classification, monitoring and therapy in pediatric rheumatology (PRO-KIND): Chronic non-bacterial osteomyelitis (CNO). HarmProtokolle zur Klassifikation, Überwachung und Therapie in der Kinderrheumatologie (PRO-KIND): Chronisch nicht-bakterielle Osteomyelitis (CNO)
Arthritis + Rheuma 38:282-288 DOI: 10.1055/s-0038-1669796 Language: German
article icon Abstract

Hinze CH, Holzinger D, Lainka E, Haas JP, Speth F, Kallinich T, Rieber N, Hufnagel M, Jansson A, Hedrich C, Winowski H, Berger T, Foeldvari I, Ganser G, Hospach T, Huppertz H-I, Mönkemöller K, Neudorf U, Weißbarth-Riedel E, Wittkowski H, Horneff G, Foell D; PRO-KIND SJIA project (2018).
Practice and consensus-based diagnostic strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.
Pediatric Rheumatology Online Journal 16:7 DOI: 10.1186/s12969-018-0224-2 Language: English
article icon Abstract

Hinze CH, Holzinger D, Lainka E, Haas JP, Speth F, Kallinich T, Minden K, Rieber N, Hufnagel M, Jansson A, Hedrich C, Winowski H, Horneff G, Foell D für die PRO-KIND SJIA-Projektgruppe (2017).
Harmonization of diagnostics and therapy of systemic-onset juvenile idiopathic arthritis in Germany: Process description and key messages. Harmonisierung der Diagnostik und Therapie der systemischen juvenilen idiopathischen Arthritis in Deutschland: Prozessbeschreibung und Kernaussagen
Arthritis + Rheuma 37:250-259 DOI: 10.1055/s-0037-1618435 Language: German
article icon Abstract

Bielicki JA, Sharland M, Johnson AP, Henderson KL, Cromwell DA; Antibiotic Resistance and Prescribing in European Children project. (* Dr. Markus Hufnagel is a contributing member of the ARPEC (Antibiotic Prescribing and Resistance in European Children) Project) (2016).
Selecting appropriate empirical antibiotic regimens for paediatric bloodstream infections: application of a Bayesian decision model to local and pooled antimicrobial resistance surveillance data.
Journal of Antimicrobial Chemotherapy 71:794-802 DOI: 10.1093/jac/dkv397 Language: English
article icon Abstract

Grom AA, Ilowite NT, Pascual V, Brunner HI, Martini A, Lovell D, Ruperto N; Paediatric Rheumatology International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group*, Leon K, Lheritier K, Abrams K. (* Dr. Markus Hufnagel is a contributing member of the Paediatric Rheumatology International Trials Organisation) (2016).
Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab.
Arthritis and Rheumatology 68:218-28 DOI: 10.1002/art.39407 Language: English
article icon Abstract

Rosini R, Campisi E, De Chiara M, Tettelin H, Rinaudo D, Toniolo C, Metruccio M, Guidotti S, Skov Sørensen UB, Kilian M, Ramirez M, DEVANI Consortium*, Janulczyk R, Donati C, Grandi G, Margarit I. (* Dr. Markus Hufnagel is a contributing member of the DEVANI (Design of a Vaccine Against Neonatal Infections) Study Group) (2015).
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population.
PLoS ONE 10:e0125985 DOI: 10.1371/journal.pone.0125985 Language: English
article icon Abstract

Lestner JM, Versporten A, Doerholt K, Warris A, Roilides E, Sharland M, Bielicki J, Goossens H, ARPEC Project Group. (* Dr. Markus Hufnagel is a contributing member of the ARPEC (Antibiotic Prescribing and Resistance in European Children) Project) (2015).
Systematic antifungal prescribing in neonates and children: Outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) study.
Antimicrobial Agents and Chemotherapy 59:782-789 DOI: 10.1128/AAC.04109-14 Language: English
article icon Abstract

de Jong MD, Reusken C, Horby P, Koopmans M, Bonten M, Chiche JD, Giaquinto C, Welte T, Leus F, Schotsman J, Goossens H, on behalf of the PREPARE consortium and affiliated clinical networks. (* Dr. Markus Hufnagel is a contributing member of the PREPARE Consortium) (2014).
Preparedness for admission of patients with suspected Ebola virus disease in European hospitals: a survey, August-September 2014.
EuroSurveillance 19(48):pii=20980 DOI: 10.2807/1560-7917.es2014.19.48.20980 Language: English
article icon Abstract

Da Cunha V, Davies MR, Douarre PE, Rosinski-Chupin I, Margarit I, Spinali S, Perkins T, Lechat P, Dmytruk N, Sauvage E, Ma L, Romi B, Tichit M, Lopez-Sanchez MJ, Descorps-Declere S, Souche E, Buchrieser C, Trieu-Cuot P, Moszer I, Clermont D, Maione D, Bouchier C, McMillan DJ, Parkhill J, Telford JL, Dougan G, Walker MJ; DEVANI Consortium*, Holden MT, Poyart C, Glaser P. (* Dr. Markus Hufnagel is a contributing member of the DEVANI (Design of a Vaccine Against Neonatal Infections) Study Group) (2014).
Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.
Nature Communications 5:4544 DOI: 10.1038/ncomms5544 Language: English
article icon Abstract

Afshar B, Broughton K, Creti R, Detcheva A, Hufnagel M, Kriz P, Lambertsen L, Lovgren M, Melin P, Orefici G, Poyart C, Radtke A, Rodriguez-Granger J, Skov Sørensen UB, Telford J, Valinsky L, Zachariadou L, Members of the DEVANI study group*, Efstratiou A. (* Dr. Markus Hufnagel is a contributing member of the DEVANI (Design of a Vaccine Against Neonatal Infections) Study Group.) (2011).
International External Quality Assurance for Laboratory Diagnosis and Typing of Streptococcus agalactiae (group B streptococci).
Journal of Clinical Microbiology 49:1475-1482 DOI: 10.1128/JCM.02365-10 Language: English
article icon Abstract

Medical Guidelines

Agyeman P, Berger C, Bochennek K, Butzer S, Groll A, Hamprecht A, Hoehl S, Hufnagel M, Laws HJ, Lehrnbecher T, Martin L, Neuberth J, Poyer F, Rudolph H, Schneider D, Simon A, Strenger V, Vieth S, Winkler B, Zöllner S. (2024).
Diagnostics and therapy of fever without source in granulocytopenic patients (S2k guideline; AWMF register number 048/014). Diagnostik und Therapie bei Fieber ohne Fokus während der Granulozytopenie (S2k-Leitlinie; AWMF-Registernummer 048/014)
S2k-Leitlinie AWMF-Registernummer 048/014 DOI: Language: German
article icon Abstract

Medical Reviews

Töpfner N, Alberer M, Ankermann T, Bender S, Berner R, de Laffolie J, Dingemann J, Heinicke D, Haas J-P, Hufnagel M, Hummel T, Huppertz H-I, Knuf M, Kobbe R, Lücke T, Riedel J, Rosenecker J, Wölfle J; Schneider B, Schneider D, Schriever V, Schroeder A, Stojanov S, Tenenbaum T, Trapp S, Vilser D, Brinkmann F, Behrends U (2022).
Recommendation for standardized medical care for children and adolescents with long COVID. Einheitliche Basisversorgung von Kindern und Jugendlichen mit Long COVID. Stellungnahme einer multidisziplinären Arbeitsgruppe der DGKJ-Konvent-Gesellschaften (Stand: Februar 2022)
Monatsschrift Kinderheilkunde 170:539-547 DOI: 10.1007/s00112-021-01408-1 Language: German
article icon Abstract

Simon A, Tenenbaum T, Huppertz HI, Trapp S, Prelog M, Hufnagel M, Knuf M, Rose MA, Forster J, Nicolai T, Berger C, Nadal D, Hübner J, Berner R, Liese J (2017).
Diagnosis and therapy of respiratory tract infections (without community-acquired pneumonia) in pediatric outpatients without severe underlying diseases. Diagnose und Therapie von Atemwegsinfektionen (ohne ambulant erworbene Pneumonie) bei ambulant behandelten Kindern ohne schwerwiegende Grunderkrankung
Monatsschrift Kinderheilkunde 165:711–724 DOI: Language: German
article icon Abstract

Textbook Contributions

Elling R, Hufnagel M, Laws HJ, Nadal D, Ritz N (2018).
Lymphadenitis colli infections. (Lymphadenitis colli-Infektionen)
Chapter(s) in "DGPI Handbuch: Infektionen bei Kindern und Jugendlichen" ("DGPI Handbook of Infectious Diseases in Children and Adolescents"), eds. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Georg Thieme Verlag, Stuttgart, pp. 207-212. ISBN: 9783132408142. Language: German.
article icon Reference

Nicolai T, Agyeman P, Hübner J, Hufnagel M, Schaad UB, Wirbelauer J (2018, 2013).
Sepsis after the neonatal period. (Sepsis jenseits der Neonatalperiode)
Chapter(s) in "DGPI Handbuch: Infektionen bei Kindern und Jugendlichen" ("DGPI Handbook of Infectious Diseases in Children and Adolescents"), eds. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Georg Thieme Verlag, Stuttgart, pp. 292-296. ISBN: 9783132408142. Language: German.
article icon Reference

Lander F, Berner R, Herting E, Hufnagel M, Kunze M, Spellerberg B (2018, 2013).
Group B streptococcus infections (GBS). (Streptokokken-Gruppe B-Infektionen (GBS))
Chapter(s) in "DGPI Handbuch: Infektionen bei Kindern und Jugendlichen" ("DGPI Handbook of Infectious Diseases in Children and Adolescents"), eds. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Georg Thieme Verlag, Stuttgart, pp. 759-763. ISBN: 9783132408142. Language: German.
article icon Reference

Hufnagel M, Knuf M (2018, 2013, 2009, 2003, 2000).
Leptospirosis. (Legionellose)
Chapter(s) in "DGPI Handbuch: Infektionen bei Kindern und Jugendlichen" ("DGPI Handbook of Infectious Diseases in Children and Adolescents"), eds. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Georg Thieme Verlag, Stuttgart, pp. 596-598. ISBN: 9783132408142. Language: German.
article icon Reference

Hufnagel M, Lemmen SW, Lück C (2018, 2013, 2009, 2003, 2000).
Legionella. (Legionellose)
Chapter(s) in "DGPI Handbuch: Infektionen bei Kindern und Jugendlichen" ("DGPI Handbook of Infectious Diseases in Children and Adolescents"), eds. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Georg Thieme Verlag, Stuttgart, pp. 584-586. ISBN: 9783132408142. Language: German.
article icon Reference

Hufnagel M, Kitz C, Panning M, Schmiedel S (2018, 2013).
Viral Hemorrhagic Fevers. (Hämorrhagische Fieber durch Viren)
Chapter(s) in "DGPI Handbuch: Infektionen bei Kindern und Jugendlichen" ("DGPI Handbook of Infectious Diseases in Children and Adolescents"), eds. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Georg Thieme Verlag, Stuttgart, pp. 496-505. ISBN: 9783132408142. Language: German.
article icon Reference

Hufnagel M, Heininger U, Hübner J (2018, 2013).
Enterococcal Infections. (Enterokokken-Infektionen)
Chapter(s) in "DGPI Handbuch: Infektionen bei Kindern und Jugendlichen" ("DGPI Handbook of Infectious Diseases in Children and Adolescents"), eds. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Georg Thieme Verlag, Stuttgart, pp. 460-463. ISBN: 9783132408142. Language: German.
article icon Reference

Hufnagel M, Panning M (2018, 2013).
Dengue Fever. (Dengue-Fieber)
Chapter(s) in "DGPI Handbuch: Infektionen bei Kindern und Jugendlichen" ("DGPI Handbook of Infectious Diseases in Children and Adolescents"), eds. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Georg Thieme Verlag, Stuttgart, pp. 435-438. ISBN: 9783132408142. Language: German.
article icon Reference

Ritz N, Hufnagel M (2018, 2013).
Chikungunya Fever. (Chikungunya-Fieber)
Chapter(s) in "DGPI Handbuch: Infektionen bei Kindern und Jugendlichen" ("DGPI Handbook of Infectious Diseases in Children and Adolescents"), eds. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Georg Thieme Verlag, Stuttgart, pp. 409-410. ISBN: 9783132408142. Language: German.
article icon Reference

Huppertz HI, Hufnagel M, Niehues T, Urschel S (2018, 2013).
Infection prophylaxis for special risks: Immunomodulatory therapy. (Infektionsprophylaxe bei speziellen Risiken: Immunmodulatorische Therapie)
Chapter(s) in "DGPI Handbuch: Infektionen bei Kindern und Jugendlichen" ("DGPI Handbook of Infectious Diseases in Children and Adolescents"), eds. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Georg Thieme Verlag, Stuttgart, pp. 140-143. ISBN: 9783132408142. Language: German.
article icon Reference

Hufnagel M, Schmitt HJ (2014, 2007, 2003, 2001).
Chlamydia Infections. (Chlamydien-Infektionen)
Chapter(s) in "Pädiatrie Grundlagen und Praxis" ("Pediatric Fundamentals and Practice"), eds. Hoffmann GF, Lentze MJ, Spranger J, Zepp F. Springer Verlag, Berlin, pp. 889-891. ISBN: 9783642418655. Language: German.
article icon Reference

Hufnagel M, Schmitt HJ (2014, 2007, 2003, 2001).
Q-Fever. (Q-Fieber)
Chapter(s) in "Pädiatrie Grundlagen und Praxis" ("Pediatric Fundamentals and Practice"), eds. Hoffmann GF, Lentze MJ, Spranger J, Zepp F. Springer Verlag, Berlin, pp. 895-896. ISBN: 978-3642418655. Language: German.
article icon Reference

Hufnagel M, Schmitt HJ (2014, 2007, 2003, 2001).
Sepsis. (Sepsis)
Chapter(s) in "Pädiatrie Grundlagen und Praxis" ("Pediatric Fundamentals and Practice"), eds. Hoffmann GF, Lentze MJ, Spranger J, Zepp F. Springer Verlag, Berlin, pp. 842-848. ISBN: 978-3642418655. Language: German.
article icon Reference

Hufnagel M, Schmitt HJ (2014, 2007, 2003, 2001).
Toxic Shock Syndrome. (Toxisches Schocksyndrom)
Chapter(s) in "Pädiatrie Grundlagen und Praxis" ("Pediatric Fundamentals and Practice"), eds. Hoffmann GF, Lentze MJ, Spranger J, Zepp F. Springer Verlag, Berlin, pp. 849-851. ISBN: 9783642418655. Language: German.
article icon Reference

Hübner J, Hufnagel M (2013).
Peritonitis. (Peritonitis)
Chapter(s) in "DGPI Handbuch: Infektionen bei Kindern und Jugendlichen" ("DGPI Handbook of Infectious Diseases in Children and Adolescents"), eds. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Georg Thieme Verlag, Stuttgart, pp. 773-775. ISBN: 9783131447166. Language: German.
article icon Reference

Bialek R, Bernard H, Hufnagel M (2013).
Q-Fever. (Q-Fieber)
Chapter(s) in "DGPI Handbuch: Infektionen bei Kindern und Jugendlichen" ("DGPI Handbook of Infectious Diseases in Children and Adolescents"), eds. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). Georg Thieme Verlag, Stuttgart, pp. 463-465. ISBN: 9783131447166. Language: German.
article icon Reference

Go to Top